Chir-98014 ct98014
WebCHIR-98014 is a selective GSK3 inhibitor; potentiate insulin activation of glucose transport and utilization in vitro and in vivo. WebIn vitro (25°C) DMSO: Warmed: 7 mg/mL (14.39 mM) Water: Insoluble: Ethanol: Insoluble: In vivo: 5% DMSO+corn oil: 1 mg/mL *<1 mg/ml means slightly soluble or insoluble. *Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values.This is normal and is due to slight batch-to-batch …
Chir-98014 ct98014
Did you know?
WebBiological Activity for CHIR 98014. CHIR 98014 is a highly potent and selective GSK-3 inhibitor (IC 50 values are 0.58 and 0.65 nM for the β and α isoforms, respectively). … WebJul 1, 2002 · GSK-3 inhibitors CHIR 98014 and CHIR 98023 were obtained from Chiron (Emeryville, CA) and have been described previously ( 26 ). They inhibit GSK-3α and -β in vitro with K = 16 nmol/l (98014) and K = 4 nmol/l (98023). K values are ≥10 μmol/l for more than 20 other kinases, including cdc2, Akt, erk, PI 3-kinase, rsk, and InsRTK ( 26 ).
WebOct 1, 2008 · Chronic inhibition of GSK-3 in human muscle cells using CT98014 and CHIR 98023 stimulated glucose transport to a level comparable to that observed with either lithium or insulin [ 40 ]. The effects of GSK-3 inhibition on glucose uptake in diabetic models has also been assessed. WebSelective cell-permeable reversible inhibitors (INHs) of GSK-3 (CT98014 and CHIR98023 [Chiron, Emeryville, CA] and LiCl) were used to evaluate the role of GSK-3 in controlling glucose metabolism....
WebCHIR 98014 is a glycogen synthase kinase-3 (GSK-3) inhibitor with IC 50 values of 0.65 nM and 0.58 nM for GSK3α and GSK3β, respectively. CHIR98014 is 500-fold to >10,000 … WebCHIR98014, also known as CT-98014, is a reversible, cell-permeable inhibitor of GSK3α and GSK3β (IC50 = 0.65 and 0.58 nM, respectively). It is inactive against a series of other serine/threonine or tyrosine kinases.
Web30 rows · Very potent, selective, cell-permeable reversible inhibitor of GSK-3; highly …
WebCHIR 98014 is a highly potent and selective GSK-3 inhibitor (IC 50 values are 0.58 and 0.65 nM for the β and α isoforms, respectively). Exhibits >500-fold selectivity for GSK-3β over a range of other kinases. rayford higginbothamWebCHIR 98014 (CHIR-98014 ); ≥ 98% HPLC; CHIR 98014 is a glycogen synthase kinase-3 (GSK-3) inhibitor with IC50 values of 0; rayford gaWeb财会201622 号财政部增值税会计处理规定逐条解读根据中华人民共和国增值税暂行条例和关于全面推开营业税改征增值税试点的通知财税201636 号等有关规定,现对增值税有关会计处理规定如下:一会计科目及专栏设置.增值税一般纳税人应当在应交税费,文库网wenkunet.com rayford hobbsWebMar 31, 2024 · Objective GSK-3 has been reported to be upregulated in malignant diseases, including lung cancers, thus suggesting it to be a valid target for cancer treatment. The study elucidates the possible mechanism involved in the ability of GSK-3 inhibitors: BIO and CHIR 98014 to regulate proteins involved in cell death of H1975 lung cancer cells. Results BIO … rayford g coatesWebCHIR 98014 is a glycogen synthase kinase-3 (GSK-3) inhibitor with IC50 values of 0.65 nM and 0.58 nM for GSK3α and GSK3β, respectively. CHIR98014 is 500-fold to >10,000-fold selectivity for GSK-3 versus 20 other protein kinases tested, including closest homologs Cdc2 and ERK2. references rayford high kpmgWebCHIR-98014" in MCE Product Catalog: Cat. No. Product Name Target Research Areas; HY-13076. CHIR-98014. GSK-3 Metabolic Disease; CHIR-98014 is a potent, cell-permeable GSK-3 inhibitor with IC 50 s of 0.65 and 0.58 nM for GSK-3 α and GSK-3β, respectively; it shows less potent activities ... simple text macbookWebCHIR-98014 is a potent, selective and ATP-competitive inhibitor of GSK3α and GSK3β (IC₅₀ = 0.65 and 0.58 nM, respectively). In addition, CHIR-98014 displays 500 to greater than … rayford griffin